In conclusion, SMS-based YXS appears effective in mitigating acute MI/R injury via suppression of oxidative stress and myocardial apoptosis, in association with upregulation of the endogenous cardio-protective nuclear receptor LXRα. The gene discussed is NR1H3; the disease is myocardial infarction.